General Information:
Id: | 1,547 |
Diseases: |
Parkinson disease
|
Homo sapiens | |
BTO:0000143 substantia nigra | |
article | |
Reference: | Zheng B et al.(2010) PGC-1alpha, a potential therapeutic target for early intervention in Parkinsons disease Sci Transl Med 2: 52RA73 [PMID: 20926834] |
Interaction Information:
Comment | The transcriptional coactivator PPARGC1A (PGC-1alpha) is a master regulator of mitochondrial biogenesis and oxidative metabolism. |
Formal Description Interaction-ID: 11054 |
|
Comment | PGC-1alpha overexpression suppresses dopaminergic neuron loss induced by A53T-synuclein and rotenone. |
Formal Description Interaction-ID: 11055 |
gene/protein decreases_activity of process |
Comment | PGC-1alpha overexpression suppresses dopaminergic neuron loss induced by A53T-synuclein and rotenone. |
Formal Description Interaction-ID: 11056 |
gene/protein decreases_activity of gene/protein mutant |
Comment | Overexpression of PGC-1alpha coactivated the expression of nuclear-encoded subunits of complex I, II, III, IV, and V of the mitochondrial ETC. |
Formal Description Interaction-ID: 11058 |
|
Comment | Genes controlling cellular bioenergetics that are expressed in response to PGC-1alpha are underexpressed in Parkinson’s disease patients. |
Formal Description Interaction-ID: 11060 |
|